广告
加载中

程天科技完成近亿元B轮融资|产业融资快报

李佳晅 2025-03-27 11:32
李佳晅 2025/03/27 11:32

邦小白快读

EN
全文速览

程天科技完成B轮融资,推动外骨骼机器人技术创新和市场应用。

1. 融资信息:公司近期获得近亿元B轮融资,由锡创投领投,资金将重点用于具身智能外骨骼技术研发、脑机新产品开发、生产基地扩建及全球市场拓展。

2. 产品与服务:已形成全场景医疗级产品矩阵,覆盖神经康复、肌骨康复等领域,累计服务用户超62.3万人次;新一代产品搭载脑机接口和脊椎电刺激,成功实施多例康复案例,如术后14天自主站立。

3. 新品与价格:2025年上市助力外骨骼机器人系列,如易行EasyGo,采用轻量化材料,无需电源提供步行助力,售价仅2500元左右,瞄准老年助行和户外运动场景。

4. 全球拓展:产品已获欧盟CE认证,加速开拓东南亚、中东、澳洲及欧洲市场,预计通过众筹方式推广新品。

品牌在外骨骼机器人领域有创新研发和差异化定价优势,抓住消费趋势拓展渠道。

1. 产品研发与创新:重点开发具身智能外骨骼技术,结合脑机接口和脊椎电刺激,提升康复效果;与顶尖医院合作验证产品,如首医宣武医院案例。

2. 消费趋势与用户行为:瞄准老年助行和户外运动等新兴消费场景,扩展产品应用从医疗康复到居家社区;新品易行EasyGo针对行动不便者需求,提供轻便解决方案。

3. 品牌定价与价格竞争:采用低价策略,如易行系列售价2500元,远低于行业水平;模组成本仅为行业1/10,整机毛利达均值2倍以上。

4. 市场渠道建设:通过全球拓展策略,包括东南亚、欧洲市场,并计划以海外众筹方式上市新品,加速品牌全球化。

市场增长机会显著,聚焦康复外骨骼领域的新商业模式和可学习点。

1. 增长市场与机会:全球市场加速拓展,产品获欧盟CE认证,进入东南亚、中东等地;2025年新品速行GoGo助力外骨骼通过众筹面向消费者,提供销售新渠道。

2. 消费需求变化:从医疗康复延伸到消费场景,如老年助行和户外运动,新品需求增加;成功案例如术后28天行走,证实产品有效性。

3. 可学习点与应对措施:核心元件100%国产化,模组成本低、毛利高,可借鉴成本控制策略;生产基地扩建保障供应,降低供应链风险。

4. 最新商业模式:采用众筹方式推广产品,结合全球市场拓展,形成线上线下结合模式;合作方式包括与医院合作试验。

生产启示包括国产化制造和成本优势,带来新商业机会。

1. 产品生产需求:核心元件100%国产化,降低依赖进口;融资后新增厂房扩建生产基地,保障设备生产与全球供应,提升产能。

2. 商业机会:外骨骼机器人需求增长,如康复养老和消费市场;模组成本仅为行业1/10,整机毛利高,可参与供应链合作。

3. 推进数字化启示:通过人机交互、人工智能和数据分析技术,优化生产流程;企业已服务全球40个国家,启示工厂数字化升级机会。

行业趋势向具身智能外骨骼普及,新技术解决客户痛点。

1. 行业发展趋势:外骨骼机器人应用扩展到康复养老和消费领域,全球市场加速渗透;如产品在14个城市成功实施案例。

2. 新技术创新:开发具身智能外骨骼技术,集成脑机接口、脊椎电刺激和脑脊融合系列,提升治疗效果;新品轻量化设计,无需电源。

3. 客户痛点与解决方案:针对运动功能障碍者和行动不便者痛点,提供智能产品矩阵;数据分析及云计算技术优化康复方案,如用户案例术后快速恢复。

平台可参与外骨骼机器人全球分销,管理众筹和市场拓展。

1. 商业对平台需求和问题:全球市场拓展需要平台支持分销和招商,如东南亚、欧洲等地区;新品上市需众筹平台对接消费者。

2. 平台最新做法:预计2025年以海外众筹方式推广速行GoGo助力外骨骼,面向消费者;加速产品全球化覆盖,招商潜力大。

3. 运营管理启示:基地扩建保障生产供应,平台可合作物流和库存管理;产品毛利高,降低运营风险。

产业动向涉及外骨骼机器人应用扩展,商业模式创新带来新问题启示。

1. 产业新动向:从医疗康复延伸到消费场景,如老年助行和户外运动;脑脊融合技术推动协同治疗,多案例验证效果。

2. 新问题与启示:如何平衡技术研发与市场落地,如融资用于研发迭代;国产化元件挑战供应链稳定性。

3. 商业模式:由康复养老扩展到多样化领域,创始人王天博士指出,外骨骼机器人将应用于娱乐、工业和安全领域,开辟新产业路径。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

Chengtian Tech Completes Series B Funding to Advance Exoskeleton Robot Innovation and Market Applications.

1. Funding Details: The company recently secured nearly 100 million yuan in Series B funding led by Xi Venture Capital. The capital will primarily support R&D in embodied intelligent exoskeleton technology, development of brain-computer interface products, expansion of production bases, and global market expansion.

2. Products and Services: Chengtian has established a full-scene medical-grade product portfolio covering neurological and musculoskeletal rehabilitation, serving over 623,000 users. New-generation products integrate brain-computer interfaces and spinal electrical stimulation, with successful rehabilitation cases including patients standing independently 14 days post-surgery.

3. New Products and Pricing: The EasyGo assistive exoskeleton series, launching in 2025, uses lightweight materials and requires no external power source for walking assistance. Priced at approximately 2,500 yuan, it targets elderly mobility and outdoor sports scenarios.

4. Global Expansion: Products have obtained EU CE certification, accelerating market entry into Southeast Asia, the Middle East, Australia, and Europe, with new products expected to launch via crowdfunding campaigns.

The brand demonstrates innovation and differentiated pricing in exoskeleton robotics, capitalizing on consumer trends to expand channels.

1. Product R&D and Innovation: Focus on embodied intelligent exoskeleton technology integrating brain-computer interfaces and spinal stimulation to enhance rehabilitation outcomes. Collaborations with top hospitals like Xuanwu Hospital validate product efficacy.

2. Consumer Trends and User Behavior: Targeting emerging scenarios like elderly mobility and outdoor sports, expanding applications from clinical rehabilitation to home/community use. The EasyGo series addresses mobility challenges with lightweight solutions.

3. Pricing Strategy and Competition: Adopting low-price strategies (e.g., EasyGo at 2,500 yuan, significantly below industry averages) with module costs at 1/10 of competitors and gross margins over twice the industry norm.

4. Channel Development: Global expansion into Southeast Asia and Europe, with planned overseas crowdfunding launches to accelerate brand globalization.

Significant market growth opportunities exist in rehabilitation exoskeletons, with new business models and learnable strategies.

1. Market Growth and Opportunities: Global expansion accelerated by EU CE certification entry into Southeast Asia/Middle East markets. The 2025 GoGo exoskeleton launch via crowdfunding creates new consumer sales channels.

2. Evolving Consumer Demand: Expansion from medical rehabilitation to consumer scenarios (elderly mobility/outdoor sports) drives demand. Success cases like 28-day post-surgery walking demonstrate efficacy.

3. Learnable Strategies: 100% domestic core components enable low module costs and high margins. Production base expansion ensures supply chain stability.

4. Emerging Business Models: Crowdfunding campaigns combined with global market expansion form hybrid online-offline models. Hospital partnerships facilitate clinical validation.

Production insights highlight localization advantages and cost efficiencies, creating new business opportunities.

1. Manufacturing Requirements: 100% domestic core components reduce import reliance. Post-funding factory expansions secure global supply chain and boost capacity.

2. Business Opportunities: Growing demand in rehabilitation/consumer exoskeletons. Module costs at 1/10 industry average with high gross margins enable supply chain partnerships.

3. Digital Transformation: Human-machine interaction, AI, and data analytics optimize production. Global reach across 40 countries demonstrates digital upgrade potential.

Industry trends show embodied intelligent exoskeleton adoption rising, with new technologies addressing client pain points.

1. Industry Trends: Exoskeleton applications expanding from rehabilitation to consumer eldercare, with global penetration accelerating. Successful implementations across 14 cities.

2. Technological Innovation: Embodied intelligence integrating brain-computer interfaces, spinal stimulation, and brain-spine fusion systems improves outcomes. New products feature lightweight, battery-free designs.

3. Client Solutions: Addressing motor impairment challenges with smart product matrices. Data analytics and cloud computing optimize rehabilitation protocols, enabling rapid recovery cases.

Platforms can participate in global exoskeleton distribution, managing crowdfunding and market expansion.

1. Platform Needs: Global expansion requires platform support for distribution/partnership recruitment in Southeast Asia/Europe. New product launches need crowdfunding platform integration.

2. Platform Strategies: Planned 2025 GoGo exoskeleton overseas crowdfunding targets consumers directly. High partnership potential in globalization efforts.

3. Operational Insights: Production base expansions ensure supply chain stability for platform logistics/inventory management. High margins reduce operational risks.

Industry dynamics show exoskeleton application diversification, with business model innovations raising new research questions.

1. Industry Trends: Expansion from medical rehabilitation to consumer scenarios (elderly mobility/outdoor sports). Brain-spine fusion technology enables synergistic therapies with multi-case validation.

2. Research Challenges: Balancing R&D iteration with market deployment (e.g., funding allocation). Domestic component sourcing tests supply chain resilience.

3. Business Models: Founder Dr. Wang Tian notes expansion into entertainment, industrial, and security fields, creating new industry pathways beyond rehabilitation.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

【亿邦原创】日前,程天科技宣布完成近亿元B轮融资。本轮融资由锡创投领投,将重点用于具身智能外骨骼技术研发迭代、脑机新产品研发注册、生产基地扩建以及全球市场拓展,进一步推动具身智能外骨骼穿戴机器人在康复养老与消费市场的应用落地,加速海内外渠道网络拓展。

程天科技成立于2017年,是一家研发康复与养老外骨骼机器人的企业,通过人机交互技术、人工智能技术、数据分析及云计算技术,面向神经损伤导致的运动功能障碍者和行动不便者提供智能化产品和解决方案。目前,程天科技已形成覆盖神经康复、肌骨康复、行动代偿等全场景医疗级产品矩阵,累计服务用户超62.3万人次。

程天科技新一代搭载脑机接口、脊椎电刺激、“脑脊融合”系列康复外骨骼产品已经与首医宣武医院、复旦华山医院等顶尖机构合作,成功实施多例“脊髓电刺激+外骨骼”协同治疗,在车祸受伤后不能行走一年后进行手术,术后14天实现自主站立,28天完成5米独立行走的用户案例,并且在全国进行扩大实验,超过14个城市已经有成功实施的案例。

程天科技创始团队与研发团队深耕外骨骼机器人领域十余年,目前公司产品核心元件100%国产化,模组成本仅为行业1/10,整机毛利达行业均值2倍以上,同时也是具身智能技术硬件核心部件的重要供应商,已服务国内外40个国家和地区的各类机器人技术公司。

在拓展全球化市场方面,程天科技经典悠行UGO系列康复外骨骼产品于2024年底获欧盟CE认证,加速开拓东南亚、中东、澳洲及欧洲市场,康复外骨骼产品的全球化进程迈入新阶段。与此同时,预计于2025年下半年上市的有源系列速行GoGo的助力外骨骼机器人,将以海外众筹的方式面向消费者开放,进一步推动全球范围内具身智能产品的有效覆盖,而此次融资后的新增厂房的落地实施,将有效保障外骨骼机器人设备的生产与全球供应。

程天科技全新系列助力外骨骼机器人产品瞄准老年助行、户外运动等消费场景,将外骨骼应用从医疗康复场景延伸到居家社区与户外休闲。2025年上市的易行EasyGo助力外骨骼机器人系列产品,产品采用轻量化碳纤维材料与仿生结构,无需电源即可提供步行助力,售价仅在2500元左右。

程天科技创始人王天博士表示:“科技应该服务于每一个人,尤其是那些因为身体原因而无法独立生活的人,因为机器人技术本来就是为了让人活得更轻松、体面、有尊严,这个理念也促使我们在外骨骼机器人领域不断探索和创新。外骨骼机器人也不只是一个康复养老的产品,外骨骼机器人是一个独立的机器人品类,大家也将会看到程天的外骨骼机器人也将在娱乐、工业、安全、交通等领域更多的应用”。

文章来源:亿邦动力

广告
微信
朋友圈

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0